top of page

Pharmaceutical Research & Development Partner

Are you a pharmaceutical company, research institution, or biotech firm passionate about advancing oral health? PerioTrap Pharmaceuticals's Pharmaceutical Research & Development Partner Program is designed to bring together like-minded organizations to collaborate on innovative therapies for periodontitis. By partnering with PerioTrap, you will gain access to cutting-edge research, clinical trial support, and co-development opportunities that will accelerate the delivery of new treatments to market.

—Pngtree—no image vector illustration isolated_4979075.png

Partnership Program :

Innovation

Target Partner Location :

Worldwide

Target Partner Persona :

Pharmaceutical companies, biotech firms, research institutions, academic researchers, and healthcare professionals with a focus on developing novel therapeutic solutions for oral diseases, periodontitis, and related conditions.

🌟 Key Benefits of the Program:

  • Collaborative Research: Partner with PerioTrap Pharmaceuticals to co-develop innovative therapies for periodontitis and other oral health challenges.
  • Access to Cutting-Edge Science: Benefit from exclusive access to PerioTrap's advanced research and technology in the field of anti-infective therapies.
  • Clinical Trial Support: Leverage PerioTrap's expertise and infrastructure to conduct clinical trials for new products, accelerating their path to market.
  • Regulatory and Development Expertise: Receive expert guidance on navigating regulatory requirements and development processes to bring new therapies to the market faster.
  • Market Penetration: Help shape the future of oral healthcare by bringing effective, evidence-based treatments to global markets.

✅ Eligibility Criteria:

  • Pharmaceutical companies or biotech firms focused on oral health and related conditions.
  • Research institutions with capabilities in clinical trials, medical device development, or therapeutic research.
  • Partners interested in co-developing new therapies for periodontitis and collaborating on scientific research.

Rich Text

Frequently asked questions

There is no FAQs yet.

End User

Apply
Transferwise logo.png

PerioTrap Pharmaceuticals GmbH

Size :

11-50

Location :

Germany

Industry:

Pharmaceuticals

default.jpg

Pierre Tangermann

CEO

Apply

Other Collab Calls

Investment & Funding Partner

Investment
Worldwide

Venture capital firms, corporate investors, family offices, and strategic healthcare investors seeking early participation in high-impact biotech ventures

Klepsydra Edge AI Integration Partner Program

Integration
Worldwide

Aerospace integrators, robotics system providers, automotive OEMs, industrial automation firms, and IoT edge device manufacturers eager to enhance products with efficient onboard AI

bottom of page